Robert T O'Donnell, MD; PhD

Professor

  • 2559 Citations
  • 29 h-Index
1979 …2019
If you made any changes in Pure, your changes will be visible here soon.

Research Output 1979 2019

  • 2559 Citations
  • 29 h-Index
  • 89 Article
  • 1 Letter
2019
Acute Myeloid Leukemia
liposomal doxorubicin
Bortezomib
2018
2 Citations (Scopus)

A phase I trial of escalating doses of cixutumumab (IMC-A12) and sorafenib in the treatment of advanced hepatocellular carcinoma

El-Khoueiry, A. B., O'Donnell, R. T., Semrad, T., Mack, P., Blanchard, S., Bahary, N., Jiang, Y., Yen, Y., Wright, J., Chen, H., Lenz, H. J. & Gandara, D. R., Mar 8 2018, (Accepted/In press) In : Cancer Chemotherapy and Pharmacology. p. 1-7 7 p.

Research output: Contribution to journalArticle

Toxicity
Hepatocellular Carcinoma
Somatomedins
Liver Neoplasms
Peritonitis
2 Citations (Scopus)

A purified, fermented, extract of Triticum aestivum has lymphomacidal activity mediated via natural killer cell activation

Barisone, G., O'Donnell, R. T., Ma, Y., Abuhay, M. W., Lundeberg, K., Gowda, S. & Tuscano, J., Jan 1 2018, In : PLoS One. 13, 1, e0190860.

Research output: Contribution to journalArticle

wheat germ
natural killer cells
non-Hodgkin lymphoma
Natural Killer Cells
Non-Hodgkin's Lymphoma
2016
4 Citations (Scopus)

The HB22.7–vcMMAE antibody–drug conjugate has efficacy against non-Hodgkin lymphoma mouse xenografts with minimal systemic toxicity

Abuhay, M., Kato, J., Tuscano, E., Barisone, G., Sidhu, R. S., O'Donnell, R. T. & Tuscano, J., Oct 1 2016, In : Cancer Immunology, Immunotherapy. 65, 10, p. 1169-1175 7 p.

Research output: Contribution to journalArticle

Heterografts
Non-Hodgkin's Lymphoma
Sulfhydryl Compounds
Cell Line
B-Cell Lymphoma
2015
2 Citations (Scopus)

Efficacy of combined histone deacetylase and checkpoint kinase inhibition in a preclinical model of human Burkitt lymphoma

Kong, Y. G., Barisone, G., Sidhu, R. S., O'Donnell, R. T. & Tuscano, J., Aug 24 2015, In : Molecular Medicine. 21, p. 824-832 9 p.

Research output: Contribution to journalArticle

Histone Deacetylases
Burkitt Lymphoma
Histone Deacetylase Inhibitors
Phosphotransferases
Checkpoint Kinase 2
2014
2 Citations (Scopus)

Histone deacetylase inhibition enhances the lymphomacidal activity of the anti-CD22 monoclonal antibody HB22.7

Kong, Y., Barisone, G., Abuhay, M., O'Donnell, R. T., Buksh, Z., Yousefian, F. & Tuscano, J., Nov 1 2014, In : Leukemia Research. 38, 11, p. 1320-1326 7 p.

Research output: Contribution to journalArticle

Histone Deacetylases
Histone Deacetylase Inhibitors
Monoclonal Antibodies
Non-Hodgkin's Lymphoma
Neoplasms
52 Citations (Scopus)

Lenalidomide plus rituximab can produce durable clinical responses in patients with relapsed or refractory, indolent non-Hodgkin lymphoma

Tuscano, J., Dutia, M., Chee, K., Brunson, A., Reed-Pease, C., Abedi, M., Welborn, J. L. & O'Donnell, R. T., 2014, In : British Journal of Haematology. 165, 3, p. 375-381 7 p.

Research output: Contribution to journalArticle

Non-Hodgkin's Lymphoma
Disease-Free Survival
lenalidomide
Rituximab
Lymphopenia
2013
14 Citations (Scopus)

Efficacy of a CD22-targeted antibody-saporin conjugate in a xenograft model of precursor-B cell acute lymphoblastic leukemia

Kato, J., Satake, N., O'Donnell, R. T., Abuhay, M., Lewis, C. & Tuscano, J., Jan 2013, In : Leukemia Research. 37, 1, p. 83-88 6 p.

Research output: Contribution to journalArticle

Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
Precursor Cell Lymphoblastic Leukemia-Lymphoma
Heterografts
Antibodies
Philadelphia Chromosome
16 Citations (Scopus)

Implementation of timeline reforms speeds initiation of National Cancer Institute-sponsored trials

Abrams, J. S., Mooney, M. M., Zwiebel, J. A., Korn, E. L., Friedman, S. H., Finnigan, S. R., Schettino, P. R., Denicoff, A. M., Kruhm, M. G., Montello, M., Misra, R. R., Ansher, S. S., Dipiazza, K. J., Souhan, E. M., Wickerham, D. L., Giantonio, B. J., O'Donnell, R. T., Sullivan, D. M., Soto, N. I., Fleming, G. F. & 11 others, Prindiville, S. A., Petryshyn, R. A., Hautala, J. A., Grad, O., Zuckerman, B. L., Meyer, R. M., Yao, J. C., Baker, L. A., Buckner, J. C., Hortobagyi, G. N. & Doroshow, J. H., Jul 3 2013, In : Journal of the National Cancer Institute. 105, 13, p. 954-959 6 p.

Research output: Contribution to journalArticle

National Cancer Institute (U.S.)
Clinical Trials
Research Personnel
TimeLine
Research
37 Citations (Scopus)

Targeting CD22 in B-cell malignancies: Current status and clinical outlook

Sullivan-Chang, L., O'Donnell, R. T. & Tuscano, J., Aug 2013, In : BioDrugs. 27, 4, p. 293-304 12 p.

Research output: Contribution to journalArticle

B-Lymphocytes
Monoclonal Antibodies
Antibodies
Neoplasms
Pharmaceutical Preparations
2012
17 Citations (Scopus)

CD22 antigen is broadly expressed on lung cancer cells and is a target for antibody-based therapy

Tuscano, J., Kato, J., Pearson, D., Xiong, C., Newell, L., Ma, Y., Gandara, D. R. & O'Donnell, R. T., Nov 1 2012, In : Cancer Research. 72, 21, p. 5556-5565 10 p.

Research output: Contribution to journalArticle

Sialic Acid Binding Ig-like Lectin 2
Lung Neoplasms
Antibodies
Therapeutics
Neoplasm Metastasis
44 Citations (Scopus)

Disulfide cross-linked micelles for the targeted delivery of vincristine to B-cell lymphoma

Kato, J., Li, Y., Xiao, K., Lee, J. S., Luo, J., Tuscano, J., O'Donnell, R. T. & Lam, K., Jun 4 2012, In : Molecular Pharmaceutics. 9, 6, p. 1727-1735 9 p.

Research output: Contribution to journalArticle

Micelles
Vincristine
B-Cell Lymphoma
Disulfides
Maximum Tolerated Dose
12 Citations (Scopus)

Efficacy and toxicity of a CD22-targeted antibody-saporin conjugate in a xenograft model of non-hodgkin's lymphoma

Kato, J., O'Donnell, R. T., Abuhay, M. & Tuscano, J., 2012, In : OncoImmunology. 1, 9, p. 1469-1475 7 p.

Research output: Contribution to journalArticle

Heterografts
Non-Hodgkin's Lymphoma
Antibodies
Pharmaceutical Preparations
Neoplasms

Moxetumomab pasudotox: Anti-CD22 immunotoxin oncolytic

Kato, J., O'Donnell, R. T. & Tuscano, J., 2012, In : Drugs of the Future. 37, 8, p. 567-570 4 p.

Research output: Contribution to journalArticle

Immunotoxins
Exotoxins
Pseudomonas
Hairy Cell Leukemia
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2011
10 Citations (Scopus)

The Bs20x22 anti-CD20-CD22 bispecific antibody has more lymphomacidal activity than do the parent antibodies alone

Tuscano, J., Ma, Y., Martin, S. M., Kato, J. & O'Donnell, R. T., Jun 2011, In : Cancer Immunology, Immunotherapy. 60, 6, p. 771-780 10 p.

Research output: Contribution to journalArticle

Bispecific Antibodies
Monoclonal Antibodies
Antibodies
Heterografts
Neoplasms
4 Citations (Scopus)

The HB22.7 Anti-CD22 monoclonal antibody enhances bortezomib-mediated lymphomacidal activity in a sequence dependent manner

Martin, S. M., Churchill, E., McKnight, H., Mahaffey, C. M., Ma, Y., O'Donnell, R. T. & Tuscano, J., 2011, In : Journal of Hematology and Oncology. 4, 49.

Research output: Contribution to journalArticle

Monoclonal Antibodies
Non-Hodgkin's Lymphoma
Reactive Oxygen Species
Apoptosis
Heterografts
2010
18 Citations (Scopus)

Development and characterization of CD22-targeted pegylated-liposomal doxorubicin (IL-PLD)

O'Donnell, R. T., Martin, S. M., Ma, Y., Zamboni, W. C. & Tuscano, J., Jun 2010, In : Investigational New Drugs. 28, 3, p. 260-267 8 p.

Research output: Contribution to journalArticle

liposomal doxorubicin
1-dodecylpyridoxal
Non-Hodgkin's Lymphoma
Doxorubicin
Cell Line
35 Citations (Scopus)

Efficacy, biodistribution, and pharmacokinetics of CD22-targeted pegylated liposomal doxorubicin in a B-cell non-Hodgkin's lymphoma xenograft mouse model

Tuscano, J., Martin, S. M., Ma, Y., Zamboni, W. & O'Donnell, R. T., May 15 2010, In : Clinical Cancer Research. 16, 10, p. 2760-2768 9 p.

Research output: Contribution to journalArticle

B-Cell Lymphoma
Heterografts
Non-Hodgkin's Lymphoma
Pharmacokinetics
Doxorubicin
2009
6 Citations (Scopus)
Heterografts
Immunotherapy
Epitopes
Lymphoma
Appointments and Schedules
9 Citations (Scopus)
Subcutaneous Injections
Intraperitoneal Injections
Heterografts
Intravenous Injections
Non-Hodgkin's Lymphoma
4 Citations (Scopus)

Phosphatase inhibition augments anti-CD22-mediated signaling and cytotoxicity in non-hodgkin's lymphoma cells

O'Donnell, R. T., Pearson, D., McKnight, H. C., Ma, Y. P. & Tuscano, J., Jul 2009, In : Leukemia Research. 33, 7, p. 964-969 6 p.

Research output: Contribution to journalArticle

Phosphoric Monoester Hydrolases
Non-Hodgkin's Lymphoma
Non-Receptor Type 6 Protein Tyrosine Phosphatase
Vanadates
B-Cell Lymphoma
5 Citations (Scopus)

Treatment of non-Hodgkin's lymphoma xenografts with the HB22.7 anti-CD22 monoclonal antibody and phosphatase inhibitors improves efficacy

O'Donnell, R. T., Pearson, D., McKnight, H. C., Ma, Y. P. & Tuscano, J., Oct 2009, In : Cancer Immunology, Immunotherapy. 58, 10, p. 1715-1722 8 p.

Research output: Contribution to journalArticle

Phosphoric Monoester Hydrolases
Heterografts
Non-Hodgkin's Lymphoma
Monoclonal Antibodies
Non-Receptor Type 6 Protein Tyrosine Phosphatase
2007
2 Citations (Scopus)

Effect of antilymphoma antibody, 131I-Lym-1, on peripheral blood lymphocytes in patients with non-Hodgkin's lymphoma

Schillaci, O., Denardo, G. L., DeNardo, S. J., Goldstein, D. S., Kroger, L. A., O'Donnell, R. T. & Lamborn, K. R., Aug 2007, In : Cancer Biotherapy and Radiopharmaceuticals. 22, 4, p. 521-530 10 p.

Research output: Contribution to journalArticle

Non-Hodgkin's Lymphoma
Lymphocytes
Antibodies
Lymphocyte Count
Spleen
169 Citations (Scopus)

Epidemiology of venous thromboembolism in 9489 patients with malignant glioma

Semrad, T., O'Donnell, R. T., Wun, T., Chew, H. K., Harvey, D. J., Zhou, H. & White, R. H., Apr 2007, In : Journal of Neurosurgery. 106, 4, p. 601-608 8 p.

Research output: Contribution to journalArticle

Venous Thromboembolism
Glioma
Epidemiology
Neurosurgery
Confidence Intervals
2006
3 Citations (Scopus)

Comparison of normal tissue pharmacokinetics with 111In/90Y monoclonal antibody m170 for breast and prostate cancer

Lehmann, J., Denardo, G. L., Yuan, A., Shen, S., O'Donnell, R. T., Richman, C. M. & DeNardo, S. J., Nov 15 2006, In : International Journal of Radiation Oncology Biology Physics. 66, 4, p. 1192-1198 7 p.

Research output: Contribution to journalArticle

antibodies
breast
Prostatic Neoplasms
Pharmacokinetics
cancer
12 Citations (Scopus)

Nuclear localizing sequences: An innovative way to improve targeted radiotherapy

O'Donnell, R. T., May 1 2006, In : Journal of Nuclear Medicine. 47, 5, p. 738-739 2 p.

Research output: Contribution to journalArticle

Radiation Oncology
Radiopharmaceuticals
Radioisotopes
Radiotherapy
Neoplasms
2005
25 Citations (Scopus)

Enhancement of the therapeutic index: From nonmyeloablative and myeloablative toward pretargeted radioimmunotherapy for metastatic prostate cancer

DeNardo, S. J., Richman, C. M., Albrecht, H., Burke, P. A., Natarajan, A., Yuan, A., Gregg, J., O'Donnell, R. T. & Denardo, G. L., Oct 1 2005, In : Clinical Cancer Research. 11, 19 II

Research output: Contribution to journalArticle

Radioimmunotherapy
Prostatic Neoplasms
Paclitaxel
Bone Marrow
Cathepsins
66 Citations (Scopus)
Radioimmunotherapy
Yttrium
Cathepsins
Indium
Paclitaxel
6 Citations (Scopus)

Planning time for peripheral blood stem cell infusion after high-dose targeted radionuclide therapy using dosimetry

Shen, S., DeNardo, S. J., Richman, C. M., Yuan, A., Siantar, C. H., O'Donnell, R. T., Kroger, L. A. & Denardo, G. L., 2005, In : Journal of Nuclear Medicine. 46, 6, p. 1034-1041 8 p.

Research output: Contribution to journalArticle

Radioisotopes
Radioactivity
Therapeutics
Radioimmunotherapy
Cell Survival
9 Citations (Scopus)

Secondary supratentorial primitive neuroectodermal tumor following irradiation in a patient with low-grade astrocytoma

Chen, A. Y., Lee, H., Hartman, J., Greco, C., Ryu, J. K., O'Donnell, R. T. & Boggan, J. E., 2005, In : American Journal of Neuroradiology. 26, 1, p. 160-162 3 p.

Research output: Contribution to journalArticle

Primitive Neuroectodermal Tumors
Astrocytoma
Cranial Irradiation
Neuroimaging
Brain Neoplasms
8 Citations (Scopus)

Splenic volume change and nodal tumor response in non-Hodgkin's lymphoma patients after radioimmunotherapy using radiolabeled Lym-1 antibody

Shen, S., Denardo, G. L., Yuan, A., Hartmann-Siantar, C., O'Donnell, R. T. & DeNardo, S. J., 2005, In : Cancer Biotherapy and Radiopharmaceuticals. 20, 6, p. 662-670 9 p.

Research output: Contribution to journalArticle

Radioimmunotherapy
Non-Hodgkin's Lymphoma
Antibodies
Neoplasms
Splenomegaly
2004
26 Citations (Scopus)
Insurance Coverage
Legislation
Clinical Trials
Costs and Cost Analysis
Insurance
2003
43 Citations (Scopus)

Anti-CD22 ligand-blocking antibody HB22.7 has independent lymphomacidal properties and augments the efficacy of 90Y-DOTA-peptide-Lym-1 in lymphoma xenografts

Tuscano, J. M., O'Donnell, R. T., Miers, L. A., Kroger, L. A., Kukis, D. L., Lamborn, K. R., Tedder, T. F. & DeNardo, G. L., May 1 2003, In : Blood. 101, 9, p. 3641-3647 7 p.

Research output: Contribution to journalArticle

Radioimmunotherapy
Blocking Antibodies
Heterografts
Lymphoma
Cells
33 Citations (Scopus)

Effect of molecular size of pegylated peptide on the pharmacokinetics and tumor targeting in lymphoma-bearing mice

DeNardo, S. J., Yao, Z., Lam, K., Song, A., Burke, P. A., Mirick, G. R., Lamborn, K. R., O'Donnell, R. T. & Denardo, G. L., Oct 1 2003, In : Clinical Cancer Research. 9, 10 II

Research output: Contribution to journalArticle

Lymphoma
Pharmacokinetics
Peptides
Neoplasms
Ligands
25 Citations (Scopus)
Radiometry
Radioimmunotherapy
Immunoconjugates
Prostatic Neoplasms
Monoclonal Antibodies
8 Citations (Scopus)

Impact of interpatient pharmacokinetic variability on design considerations for therapy with radiolabeled MAbs

Denardo, G. L., Yuan, A., Goldstein, D., Richman, C. M., O'Donnell, R. T., Shen, S., Hartmann Siantar, C. & DeNardo, S., 2003, In : Cancer Biotherapy and Radiopharmaceuticals. 18, 2, p. 231-237 7 p.

Research output: Contribution to journalArticle

Radioisotopes
Pharmacokinetics
Prescriptions
Therapeutics
Indium
29 Citations (Scopus)

Phase I trial of high-dose tamoxifen in combination with cisplatin in patients with lung cancer and other advanced malignancies

Perez, E. A., Gandara, D. R., Edelman, M. J., O'Donnell, R. T., Lauder, I. J. & DeGregorio, M., 2003, In : Cancer Investigation. 21, 1, p. 1-6 6 p.

Research output: Contribution to journalArticle

Tamoxifen
Cisplatin
Lung Neoplasms
Neoplasms
Serum
2002
58 Citations (Scopus)

Combined modality radioimmunotherapy for human prostate cancer xenografts with taxanes and 90Yttrium-DOTA-peptide-ChL6

O'Donnell, R. T., Denardo, S. J., Miers, L. A., Lamborn, K. R., Kukis, D. L., Denardo, G. L. & Meyers, F. J., Jan 1 2002, In : Prostate. 50, 1, p. 27-37 11 p.

Research output: Contribution to journalArticle

docetaxel
Radioimmunotherapy
Taxoids
Heterografts
Prostatic Neoplasms
27 Citations (Scopus)

Early diagnosis and successful treatment of a patient with transfusion-associated GVHD with autologous peripheral blood progenitor cell transplantation.

Hutchinson, K., Kopko, P. M., Muto, K. N., Tuscano, J., O'Donnell, R. T., Holland, P. V., Richman, C. M., Paglieroni, T. G. & Wun, T., Dec 2002, In : Transfusion. 42, 12, p. 1567-1572 6 p.

Research output: Contribution to journalArticle

Cell Transplantation
Exanthema
Early Diagnosis
Histocompatibility Testing
Blood Cells
2001
3 Citations (Scopus)

Metabolite production in patients with lymphoma after radiometal-labeled antibody administration

Denardo, G. L., DeNardo, S. J., Kukis, D. L., O'Donnell, R. T., Shen, S., Mirick, G. R. & Meares, C. F., 2001, In : Journal of Nuclear Medicine. 42, 9, p. 1324-1333 10 p.

Research output: Contribution to journalArticle

Lymphoma
Antibodies
Non-Hodgkin's Lymphoma
Area Under Curve
Immunoconjugates
381 Citations (Scopus)
Clinical Trials
Neoplasms
Insurance
Patient Participation
Physicians
51 Citations (Scopus)

Radioimmunotherapy with 111In/90Y-2IT-BAD-m170 for metastatic prostate cancer

O'Donnell, R. T., DeNardo, S. J., Yuan, A., Shen, S., Richman, C. M., Lara, P. N., Griffith, I. J., Goldstein, D. S., Kukis, D. L., Martinez, G. S., Mirick, G. R., Denardo, G. L. & Meyers, F. J., 2001, In : Clinical Cancer Research. 7, 6, p. 1561-1568 8 p.

Research output: Contribution to journalArticle

Radioimmunotherapy
Prostatic Neoplasms
Maximum Tolerated Dose
Pain
Prostate-Specific Antigen
5 Citations (Scopus)

Radiolabeled anti-lymphoma antibodies.

Denardo, G. L., O'Donnell, R. T. & DeNardo, S. J., 2001, In : Cancer chemotherapy and biological response modifiers. 19, p. 297-308 12 p.

Research output: Contribution to journalArticle

Radioisotopes
Anti-Idiotypic Antibodies
Lymphoma
Bispecific Antibodies
Drug Approval
2000
38 Citations (Scopus)

A phase I study of 90Y-2IT-BAD-Lym-1 in patients with non-Hodgkin's lymphoma

O'Donnell, R. T., Shen, S., Denardo, S. J., Wun, T., Kukis, D. L., Goldstein, D. S. & Denardo, G. L., 2000, In : Anticancer Research. 20, 5 C, p. 3647-3655 9 p.

Research output: Contribution to journalArticle

Non-Hodgkin's Lymphoma
Maximum Tolerated Dose
Radio
Drug Therapy
Immunotherapy
31 Citations (Scopus)

Are Radiometal-Labeled Antibodies Better Than Iodine-131-Labeled Antibodies: Comparative Pharmacokinetics and Dosimetry of Copper-67-, Iodine-131-, and Yttrium-90-Labeled Lym-1 Antibody in Patients with Non-Hodgkin's Lymphoma

Denardo, G. L., DeNardo, S. J., O'Donnell, R. T., Kroger, L. A., Kukis, D. L., Meares, C. F., Goldstein, D. S. & Shen, S., Sep 2000, In : Clinical Lymphoma. 1, 2, p. 118-126 9 p.

Research output: Contribution to journalArticle

Yttrium
Iodine
Non-Hodgkin's Lymphoma
Copper
Pharmacokinetics
10 Citations (Scopus)

Efficacy and toxicity of radioimmunotherapy with 90Y-DOTA-peptide-ChL6 for PC3-tumored mice

O'Donnell, R. T., DeNardo, S. J., Denardo, G. L., Miers, L., Lamborn, K. R., Kukis, D. L. & Meyers, F. J., Aug 1 2000, In : Prostate. 44, 3, p. 187-192 6 p.

Research output: Contribution to journalArticle

Radioimmunotherapy
Peptides
Prostatic Neoplasms
Heterografts
Nude Mice
51 Citations (Scopus)

Neovascular targeting with cyclic RGD peptide (cRGDf-ACHA) to enhance delivery of radioimmunotherapy

DeNardo, S. J., Burke, P. A., Leigh, B. R., O'Donnell, R. T., Miers, L. A., Kroger, L. A., Goodman, S. L., Matzku, S., Jonczyk, A., Lamborn, K. R. & Denardo, G. L., 2000, In : Cancer Biotherapy and Radiopharmaceuticals. 15, 1, p. 71-79 9 p.

Research output: Contribution to journalArticle

Radioimmunotherapy
Cyclic Peptides
Neoplasms
Capillary Permeability
Permeability
35 Citations (Scopus)

Radiation dosimetry for 90Y-2IT-BAD-Lym-1 extrapolated from pharmacokinetics using 111In-2IT-BAD-Lym-1 in patients with non-Hodgkin's lymphoma

DeNardo, G. L., O'Donnell, R. T., Shen, S., Kroger, L. A., Yuan, A., Meares, C. F., Kukis, D. L. & DeNardo, S. J., May 2000, In : Journal of Nuclear Medicine. 41, 5, p. 952-958 7 p.

Research output: Contribution to journalArticle

Radiometry
Non-Hodgkin's Lymphoma
Pharmacokinetics
Neoplasms
Radiation
1999
45 Citations (Scopus)

67Copper-2-iminothiolane-6-[p-(bromoacetamido)benzyl]-TETA-Lym-1 for radioimmunotherapy of non-Hodgkin's lymphoma

O'Donnell, R. T., Denardo, G. L., Kukis, D. L., Lamborn, K. R., Shen, S., Yuan, A., Goldstein, D. S., Mirick, G. R. & DeNardo, S. J., Oct 1999, In : Clinical Cancer Research. 5, 10 SUPPL.

Research output: Contribution to journalArticle

Radioimmunotherapy
Non-Hodgkin's Lymphoma
Acids
Monoclonal Antibodies
Radiometry
82 Citations (Scopus)

A clinical trial of radioimmunotherapy with 67Cu-2IT-BAT-Lym-1 for Non-Hodgkin's lymphoma

O'Donnell, R. T., Denardo, G. L., Kukis, D. L., Lamborn, K. R., Shen, S., Yuan, A., Goldstein, D. S., Carr, C. E., Mirick, G. R. & DeNardo, S. J., Dec 1999, In : Journal of Nuclear Medicine. 40, 12, p. 2014-2020 7 p.

Research output: Contribution to journalArticle

Radioimmunotherapy
Non-Hodgkin's Lymphoma
Clinical Trials
Bone Marrow
Immunoconjugates